Steady dose escalation to higher doses than for glycaemic control are indicated if: BMI is 30 kg/m 2 , or BMI 27 to 30 kg/m 2 , and for the range 2730 kg/m 2 if there is one weight-related comorbidity (hypertension, dyslipidaemia, cardiovascular disease, obstructive sleep apnoea, prediabetes or T2D
Farilla L, Hui H, Bertolotto C, Kang E, Bulotta A, Di Mario U, Perfetti R
According to the SCALE study, the basis for approving Saxenda, 3,731 patients administered with Saxenda 3mg for 56 six weeks lost at least 5 percent of the weight, and nearly half of them remained so for three years
Broad metabolic improvement or fatty liver: Retatrutide offers unique benefits
Less water means a more concentrated solution, which means smaller injection volumes
In the event of a medical emergency, such as chest pain that radiates to the arm or jaw, call 911 immediately